Europa Capital, with its partner Balzac REIM, announces the sale of Le Sémaphore to its value-added fund Europa Fund V, to a Primonial REIM fund, for €142.5 million. The sale comes shortly after a firm nine-year lease was agreed for the entire 12,000 m², eight-storey office building in Levallois-Perret. Doctolib will take possession of the asset in January 2020.